Adrián Mosquera Recognized at the Fundación ASISA Awards

Adrián Mosquera recognized at the Fundación ASISA Awards

The project led by Adrián Mosquera has been selected in the first edition of the Fundación ASISA Awards for Health Research and Social Projects.

The project led by Adrián Mosquera, founder of Código Rojo and a specialist in Hematology and Hemotherapy at the University Hospital of Santiago de Compostela, has been recognized in the first edition of the Fundación ASISA Awards for Health Research and Social Projects.

The initiative, focused on artificial intelligence applied to clinical knowledge in oncohematology, has been selected as one of the five health research projects recognized in this first edition. The award includes a €6,000 grant to support the development of the project.

The research aims to validate an artificial intelligence tool designed to facilitate safer access to clinical knowledge, as part of a research line combining artificial intelligence, genomics, and precision medicine.

Adrián Mosquera conducts his research within the Computational Hematology and Genomics Group (GrHeco-Xen) at the Health Research Institute of Santiago (IDIS), while also combining his research work with clinical practice and scientific communication.

At Código Rojo, we are pleased to celebrate this recognition and the support it provides for continued research into the applications of artificial intelligence in healthcare.

We share some moments from the awards ceremony.

Debate with AI #12 – Most beneficial non-pharmacological intervention for health

The Expert

Adrián Mosquera Orgueira

Adrián Mosquera Orgueira is a specialist in Hematology and Hemotherapy at the University Hospital of Santiago de Compostela and holds a Doctorate in Medicine from the University of Santiago de Compostela. He currently leads the Computational Hematology and Genomics Group (GrHeco-Xen) at the Santiago Health Research Institute (IDIS), focusing on the applications of genomics and artificial intelligence in the field of precision medicine. This line aims to improve the prediction of hematological cancer response to available treatments, as well as the development of personalized therapies for hematological cancer. He is the co-author of dozens of research papers in recent years, including publications in high-impact journals in the Hematology sector such as Leukemia, Blood Cancer Journal, Hemasphere, and Cancers. Additionally, he is currently involved in several research projects in the field of various hematological neoplasms. Dr. Mosquera combines this research activity with his clinical practice at CHUS and with the dissemination of scientific knowledge.

Debate with AI #11 – Three high-value measures in a healthcare system

The Expert

Adrián Mosquera Orgueira

Adrián Mosquera Orgueira is a specialist in Hematology and Hemotherapy at the University Hospital of Santiago de Compostela and holds a Doctorate in Medicine from the University of Santiago de Compostela. He currently leads the Computational Hematology and Genomics Group (GrHeco-Xen) at the Santiago Health Research Institute (IDIS), focusing on the applications of genomics and artificial intelligence in the field of precision medicine. This line aims to improve the prediction of hematological cancer response to available treatments, as well as the development of personalized therapies for hematological cancer. He is the co-author of dozens of research papers in recent years, including publications in high-impact journals in the Hematology sector such as Leukemia, Blood Cancer Journal, Hemasphere, and Cancers. Additionally, he is currently involved in several research projects in the field of various hematological neoplasms. Dr. Mosquera combines this research activity with his clinical practice at CHUS and with the dissemination of scientific knowledge.

Código Rojo receives the Medical Education Award from the Fundación Lilly – UCM 2026

Código Rojo-Premio de Educación Médica 2026-Fundación Lilly

Código Rojo receives the Medical Education Award from the Fundación Lilly – UCM 2026

Third recognition in just over a year for the continuing education project in artificial intelligence for medicine.

Código Rojo-Premio de Educación Médica 2026-Fundación Lilly

The Medical Education Chair Fundación Lilly – Universidad Complutense de Madrid has awarded Código Rojo the Prize for Best Project or Work in Postgraduate Education and Specialist Training, in the XVII edition of its awards held in 2026. The project was presented by Dr. Adrián Mosquera Orgueira, researcher at IDIS and physician at the Hospital Clínico Universitario de Santiago de Compostela, under the title «Código Rojo: continuing education and digital laboratory for the critical and safe use of AI in medicine».

These awards, convened annually by the Fundación Lilly – UCM Chair, recognise initiatives that represent educational innovation in the field of medical teaching, with particular attention to improving professional performance and the acquisition of values inherent to the medical profession. The jury is composed of professionals of recognised standing in the fields of Health Sciences and Medical Education.

This award comes after a year in which Código Rojo has accumulated several significant recognitions across different areas. In 2025, the project received the Digital Transformation Award at Ennova Health, organised by Diario Médico and Correo Farmacéutico, and the First Prize INNOVA-H 2025.

Each of these recognitions has come from a different area: digital health innovation and now postgraduate medical education. Together, they reflect the reach of a project born with a specific goal: to offer healthcare professionals a rigorous and critical way to incorporate artificial intelligence into their continuing education, through validated medical educational assistants across more than 57 specialties.

Debate with AI #10 – France’s most important scientific contribution to the history of medicine

The Expert

Adrián Mosquera Orgueira

Adrián Mosquera Orgueira is a specialist in Hematology and Hemotherapy at the University Hospital of Santiago de Compostela and holds a Doctorate in Medicine from the University of Santiago de Compostela. He currently leads the Computational Hematology and Genomics Group (GrHeco-Xen) at the Santiago Health Research Institute (IDIS), focusing on the applications of genomics and artificial intelligence in the field of precision medicine. This line aims to improve the prediction of hematological cancer response to available treatments, as well as the development of personalized therapies for hematological cancer. He is the co-author of dozens of research papers in recent years, including publications in high-impact journals in the Hematology sector such as Leukemia, Blood Cancer Journal, Hemasphere, and Cancers. Additionally, he is currently involved in several research projects in the field of various hematological neoplasms. Dr. Mosquera combines this research activity with his clinical practice at CHUS and with the dissemination of scientific knowledge.